Oncology marketing: a playbook for Indian hospitals
Cancer care marketing in India is about trust, clarity and support, not persuasion. Patients and families arrive frightened, often with a diagnosis from elsewhere, and want a second opinion, a clear plan and help with cost. Lead with multidisciplinary teams, fast second-opinion pathways, navigator support and honest financial guidance.
Why oncology marketing is different
India recorded an estimated 15.7 lakh new cancer cases in 2025, and about 1 in 9 Indians is likely to develop cancer in their lifetime. Treatment spans months and several modalities, so the relationship is long. Many patients travel to cities for care, which makes digital first contact and remote second opinions central.
Key facts for oncology marketers
| Fact | Figure | Source |
|---|---|---|
| Estimated new cancer cases (2025) | 15.70 lakh | Rajya Sabha reply via ETV Bharat |
| Estimated cancer deaths (2025) | 8.69 lakh | Rajya Sabha reply via ETV Bharat |
| Lifetime risk of developing cancer | About 1 in 9 Indians | IJMR 2022 via PubMed |
| PM-JAY coverage | Medical, surgical and radiation oncology are covered specialties | NHA HBP 2.2 manual |
How patients decide
- Suspicion or diagnosis. A test result or biopsy leads to urgent searching about the cancer type and where to go.
- Second opinion. Families share reports and seek a second view, often remotely and from another city.
- Choosing a centre. They weigh the team, technology, travel, cost and insurance.
- Treatment. Surgery, chemotherapy and radiotherapy over months, with many touchpoints.
- Survivorship. Follow-up, screening of family members and support groups.
Channels that matter most
- A dedicated second-opinion pathway: upload reports, get a call from a navigator, receive a written view within a stated time.
- Tumour board and team pages showing the specialists who review each case.
- Search ads for cancer type plus ‘treatment’ and city terms, sending to calm, informative pages with a navigator contact.
- WhatsApp navigator support with consent, for appointments, reports and financial counselling.
- Screening awareness content for breast, cervical and oral cancer, timed to awareness months.
Content to publish first
Start with the questions patients and families actually ask. Each of these should open with a short, direct answer and be reviewed by a specialist before it goes live.
- How a tumour board works and why it matters
- What to bring for a cancer second opinion
- Understanding the cost of cancer treatment and how insurance and schemes help
- What to expect in the first week of chemotherapy, for families
- Questions to ask your oncology team
- Caring for a family member during treatment
Compliance rules to know
- The Drugs and Magic Remedies Act, 1954 lists cancer and tumours: no ‘cure’ claims for any drug, supplement or remedy.
- Avoid survival or success statistics unless they are your own audited data, clearly explained and appropriately qualified.
- Patient stories in oncology need especially careful consent and should never imply that one outcome is typical.
These sit on top of the rules that apply to every specialty: the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, which remain in force after the NMC’s 2023 regulations were put in abeyance and treat soliciting patients as unethical; the CCPA’s 2022 guidelines on misleading advertisements; ASCI’s codes, including its 2025 rules for health influencers; and the DPDP Act, 2023 for every enquiry you collect. The regulation section of key statistics 2026 has the enforcement numbers, and DPDP notice and consent covers enquiry data.
Insurance and government schemes
Oncology is well covered under PM-JAY and most insurance policies, though long treatments can exceed limits. Financial counselling, clear estimates by treatment phase and help with scheme paperwork are some of the most valuable things a hospital can offer. Note that IRDAI standard exclusions still allow reconstruction after cancer surgery.
What to measure
Judge marketing on outcomes the hospital can verify, not clicks. These are the numbers I would put on a monthly dashboard:
- Second-opinion requests and time to written response
- Second opinion to treatment conversion
- Navigator response time on WhatsApp and calls
- Treatment completion at the same centre
- Share of patients from outside the city or state
The common mistake
Marketing technology, such as a new machine, ahead of the team and the patient support. Families choose people and pathways; equipment is a supporting fact.
Questions people ask
Focus on facts patients need: the team, how cases are reviewed, the second-opinion process, support services and how costs are handled. Avoid cure claims, fear-based messaging and unverified survival statistics, and have clinicians review all content.
Many patients arrive with a diagnosis from elsewhere and want reassurance before starting treatment. A clear, fast and remote-friendly second-opinion process is often the first real contact with the hospital and the main route into treatment.
Yes. Medical, surgical and radiation oncology are covered specialties in PM-JAY’s health benefit packages, within the scheme’s annual family cover. Hospitals should help eligible families with paperwork and explain any costs outside the scheme.
Part of the specialty marketing playbooks series. This guide covers marketing, patient communication and compliance; it is not clinical advice.
Related guides
- Digital marketing for doctors in India: a practical guide
- Healthcare marketing comparisons
- Treatment estimate and payer mix in the glossary
Sources
Read my takes first in Google Search
